Showing 211-220 of 5956 results for "".
EMPOWER - Optimizing Contact Lens Wear
https://modernod.com/podcasts/the-mod-pod/empower-optimizing-contact-lens-wear/36884/In this second episode of the EMPOWER series, Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, and Jessica O. Yu, OD, FAAO, FSLS, sit down with Jacob Lang, OD, FAAO, to discuss how to tackle the most common causes of contact lens dropout. With a focus on practical, evidence-based strategies, this conversatiThe Benefits of Advanced DED Diagnostics
https://modernod.com/mod-issues/2026-mar-apr/the-benefits-of-advanced-ded-diagnostics/56858/Provide your patients with minimally invasive options that offer fast results.Left Behind
https://modernod.com/topics/cataractrefractive-surgery/left-behind/39838/A rare complication of cataract surgery can cause a range of visual problems.Imaging for Evaporative DED
https://modernod.com/mod-issues/2026-mar-apr/imaging-for-evaporative-ded/56853/The pathology revealed by my diagnostic technology helped me make a definitive diagnosis.Highlights from the TFOS DEWS III Report
https://modernod.com/videos/eye-care-insiders/highlights-from-the-tfos-dews-iii-report/37359/Now in its third iteration, the latest TFOS DEWS report is a staple for any eye care provider who sees patients with dry eye and ocular surface disease. Here, Joseph J. Allen, OD, FAAO, Dipl ABO, walks you through the key takeaways, including the updated definitions, screening questionnaires, treatmContact Lens Success in Modern Optometric Clinics
https://modernod.com/programs/empower/contact-lens-success-in-modern-optometric-clinics/49028/Daily contact lens patients live their best lives when providers match their anatomy and needs to the lens that fits them best.Alcon Gains FDA Approval for Novel DED Drug
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-gains-fda-approval-for-novel-ded-drug/37087/Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more abThe Evolution of Lens Correction for Presbyopia
https://modernod.com/topics/contact-lenses/the-evolution-of-lens-correction-for-presbyopia/39023/Here’s what to keep an eye on.Lenz Therapeutics' Vizz Commerically Launched
https://modernod.com/podcasts/eyewire-news-the-podcast/lenz-therapeutics-vizz-commerically-launched/39874/A first-of-its-kind presbyopia eye drop is now commercially available; Lumibird introduces ICL Guru Integration on its ultrasound platform; and the makers of gene therapy candidates for retinal diseases provide clinical updates. Learn more about your ad choices. Visit megaphone.fm/adchoicesHow to Improve the Contact Lens Wearing Experience
https://modernod.com/mod-issues/mayjune-2025-supplement/how-to-improve-the-contact-lens-wearing-experience/38997/Evidence-based insights on the impact of various factors affecting the success of this form of vision correction.